Clinical trial
Arsenic Trioxide in Treating Patients With Advanced Solid Tumors
NCT00003630 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003630 |
|---|---|
| Title | Arsenic Trioxide in Treating Patients With Advanced Solid Tumors |
| Official title | Phase I Study of Arsenic Trioxide |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor |
| Intervention type | Drug |
| Interventions | arsenic trioxide |
| Start date | Aug 1, 1998 |
| Primary completion | Aug 1, 2000 |
| Completion | Aug 1, 2000 |
| First posted | Jun 24, 2004 |
| Last update posted | Jun 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: